References
- 1
Lo G H, Liang H L, Chen W C. et al .
A prospective, randomized controlled trial of transjugular intrahepatic portosystemic
shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
Endoscopy.
2007;
39
679-685
- 2
Papatheodoridis G V, Goulis J, Leandro G. et al .
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment
for prevention of variceal rebleeding: A meta-analysis.
Hepatology.
1999;
30
612-622
- 3
Goulis J, Armonis A, Patch D. et al .
Bacterial infection is independently associated with failure to control bleeding
in cirrhotic patients with gastrointestinal hemorrhage.
Hepatology.
1998;
27
1207-1212
- 4
Burroughs A K, Mezzanotte G, Phillips A. et al .
Cirrhotics with variceal hemorrhage: the importance of the time interval between
admission and the start of analysis for survival and rebleeding rates.
Hepatology.
1989;
9
801-807
- 5
de Franchis R.
Evolving consensus in portal hypertension. Report of the Baveno IV consensus
workshop on methodology of diagnosis and therapy in portal hypertension.
J Hepatol.
2005;
43
167-176
- 6
Garcia-Tsao G, Sanyal A J, Grace N D, Carey W D.
Prevention and management of gastroesophageal varices and variceal hemorrhage
in cirrhosis.
Am J Gastroenterol.
2007;
102
2086-2102
L. Spahr, MD
Gastroenterology and Hepatology
University Hospital of Geneva
24, Rue Micheli-du-Crest
CH-1211 Geneva 14
Switzerland
Fax: +4122-3729366
Email: Laurent.Spahr@hcuge.ch
